Future of targeted agents in metastatic colorectal cancer.
about
IgE-based Immunotherapy of Cancer -A Comparative Oncology ApproachEarly Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer.The preclinical development of regorafenib for the treatment of colorectal cancer.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer
P2860
Future of targeted agents in metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Future of targeted agents in metastatic colorectal cancer.
@en
Future of targeted agents in metastatic colorectal cancer.
@nl
type
label
Future of targeted agents in metastatic colorectal cancer.
@en
Future of targeted agents in metastatic colorectal cancer.
@nl
prefLabel
Future of targeted agents in metastatic colorectal cancer.
@en
Future of targeted agents in metastatic colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Future of targeted agents in metastatic colorectal cancer.
@en
P2093
John L Marshall
Marion L Hartley
Mauricio Burotto
Michael J Pishvaian
P2860
P356
10.2217/CRC.12.52
P577
2012-10-01T00:00:00Z